Description Module
The Description Module contains narrative descriptions of the clinical trial, including a brief summary and detailed description. These descriptions provide important information about the study's purpose, methodology, and key details in language accessible to both researchers and the general public.
Description Module path is as follows:
Study -> Protocol Section -> Description Module
Description Module
Ignite Creation Date:
2025-12-25 @ 3:29 AM
Ignite Modification Date:
2025-12-25 @ 3:29 AM
NCT ID:
NCT00666705
Brief Summary:
An open label study to evaluate an interaction between maraviroc and raltegravir in healthy subjects.
Detailed Description:
Drug interaction study
Study:
NCT00666705
Study Brief:
Protocol Section:
NCT00666705